Ahmet Gulmez

Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.

A. Bilici, S. Şahin, I. Çiçin, 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Secondary Breast Cancer after Hodgkin's Lymphoma

Ahmet Gulmez, A. Gulmez, 2019 .

The unexpected effect of the combination of lapatinib and capecitabin in cranial metastasis

Ahmet Gulmez, A. Gulmez, 2023, Journal of cancer research and therapeutics.

Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group

A. Erdoğan, A. Bilici, M. Araz, 2022, Journal of cancer research and therapeutics.

DOES COUNTRY CREDIT RATING AFFECT CURRENT DEFICIT ACCOUNT: THE CASE OF TURKEY (1992-2014)

Furkan Beşel, Fatih Yardımcıoğlu, Ahmet Gulmez, 2017 .

Impact of pharmacist-led educational intervention on pneumococcal vaccination rates in cancer patients: a randomized controlled study

A. Bayraktar-Ekincioglu, S. Kılıçkap, Serhat Unal, 2023, Supportive Care in Cancer.

Are depression and poor sleep quality a major problem in Turkish Women receiving chemotherapy for breast cancer?

M. Buyuksimsek, Mehmet Mutlu Kidi, M. Tohumcuoğlu, 2024, Revista da Associacao Medica Brasileira.

Evaluation of the efficacy of pretreatment chest CT markers in predicting response to neoadjuvant chemoradiotherapy in locally advanced non-small cell lung cancer (NSCLC)

Z. A. Taş, O. Dilek, Ahmet Gulmez, 2024, Cukurova Anestezi ve Cerrahi Bilimler Dergisi.

Acute sunitinib neurotoxicity.

H. Harputluoglu, M. Dikilitas, Ahmet Gulmez, 2021, Cancer treatment and research communications.